Hussman Strategic Advisors Inc. Takes $1.99 Million Position in Astrana Health, Inc. (NASDAQ:ASTH)

Hussman Strategic Advisors Inc. acquired a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 63,000 shares of the company's stock, valued at approximately $1,986,000. Hussman Strategic Advisors Inc. owned about 0.11% of Astrana Health at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB lifted its holdings in shares of Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after acquiring an additional 400 shares during the period. Nisa Investment Advisors LLC acquired a new stake in Astrana Health in the third quarter valued at approximately $35,000. KBC Group NV acquired a new stake in shares of Astrana Health during the third quarter worth approximately $70,000. Quarry LP acquired a new position in Astrana Health in the third quarter worth $77,000. Finally, Quest Partners LLC acquired a new position in Astrana Health in the third quarter worth $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Stifel Nicolaus cut their target price on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday. Robert W. Baird raised their target price on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. Macquarie upgraded Astrana Health to a "hold" rating in a research note on Monday, December 16th. Finally, Truist Financial cut their target price on Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $63.00.

Astrana Health Stock Down 4.6 %

NASDAQ:ASTH traded down $1.71 on Friday, hitting $35.68. 291,742 shares of the company's stock traded hands, compared to its average volume of 249,265. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 1 year low of $29.08 and a 1 year high of $63.20. The firm has a 50-day moving average price of $35.06 and a 200-day moving average price of $44.99. The company has a market cap of $2.01 billion, a PE ratio of 27.45, a price-to-earnings-growth ratio of 1.44 and a beta of 1.20.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.